{"disease":{"id":"neonatal-herpes-simplex-infection","name":"neonatal herpes simplex infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05226949","title":"Host RNA Expression Profiles and Protein Biomarkers in Neonatal Herpes Simplex Virus Infection","phase":"","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04448392","title":"Valacyclovir in Neonatal Herpes Simplex Virus Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}